The progress of Mycobacterium tuberculosis drug targets

被引:1
|
作者
Zhang, Xin [1 ]
Zhao, Ruixia [1 ]
Qi, Yao [1 ]
Yan, Xiong [1 ]
Qi, Gaoxiu [1 ]
Peng, Qiuju [2 ]
机构
[1] Univ Hlth & Rehabil Sci, Qingdao Cent Hosp, Qingdao Cent Med Grp, Qingdao, Shandong, Peoples R China
[2] Qingdao Chest Hosp, Qingdao, Shandong, Peoples R China
关键词
<italic>Mycobacterium tuberculosis</italic>; anti-tuberculosis drug; target; cell wall synthesis correlation; DNA/RNA synthesis correlation; energy metabolism; DEPENDENT REGULATOR IDER; HOST-IMMUNE-RESPONSE; INHIBITORS; POTENT; DESIGN; SQ109; DISCOVERY;
D O I
10.3389/fmed.2024.1455715
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tuberculosis (TB) has been troubling humans for hundreds of years, is a highly infectious disease caused by Mycobacterium tuberculosis (Mtb) infection, Mtb can infect almost all organs of the body and is one of the deadly infectious diseases in the world. At present, the first-line treatment regimen has a long treatment cycle and is prone to multiple drug resistance. Anti-tuberculosis drugs and latent tuberculosis infection (LTBI) resistance are increasing year by year, and new targets and new bioactive compounds are urgently needed to treat this disease. This review focuses on the latest reported anti-TB drug targets and related compounds in recent years, reviews the current TB drug regimen and major defects, outlines the key drug targets developed to date in Mtb, and the current situation of newly discovered anti-TB resistant forms of drugs. To provide a reference for the research and development of new anti-TB drugs and bring new treatment strategies for TB patients.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] New drug targets for Mycobacterium tuberculosis
    Chopra, P
    Meena, LS
    Singh, Y
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2003, 117 : 1 - 9
  • [2] Adenylating Enzymes in Mycobacterium tuberculosis as Drug Targets
    Duckworth, Benjamin P.
    Nelson, Kathryn M.
    Aldrich, Courtney C.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (07) : 766 - 796
  • [3] The Expanding Diversity of Mycobacterium tuberculosis Drug Targets
    Wellington, Samantha
    Hung, Deborah T.
    ACS INFECTIOUS DISEASES, 2018, 4 (05): : 696 - 714
  • [4] Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosis
    Rastogi, N
    Goh, KS
    VanGinkel, SZ
    Wright, EL
    Barrow, WW
    RESEARCH IN MICROBIOLOGY, 1996, 147 (1-2) : 97 - 105
  • [5] The β-Carbonic Anhydrases from Mycobacterium tuberculosis as Drug Targets
    Nishimori, Isao
    Minakuchi, Tomoko
    Maresca, Alfonso
    Carta, Fabrizio
    Scozzafava, Andrea
    Supuran, Claudiu T.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (29) : 3300 - 3309
  • [6] Identification and validation of novel drug targets in Mycobacterium tuberculosis
    Singh, Vinayak
    Mizrahi, Valerie
    DRUG DISCOVERY TODAY, 2017, 22 (03) : 503 - 509
  • [7] Structural and functional studies of drug targets for Mycobacterium tuberculosis
    Rao, Z.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2017, 46 : S171 - S171
  • [8] Proteases in Mycobacterium tuberculosis pathogenesis: potential as drug targets
    Roberts, David M.
    Personne, Yoann
    Ollinger, Juliane
    Parish, Tanya
    FUTURE MICROBIOLOGY, 2013, 8 (05) : 621 - 631
  • [9] Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis
    Bhat, Zubair Shanib
    Rather, Muzafar Ahmad
    Maqbool, Mubashir
    UL Lah, Hafiz
    Yousuf, Syed Khalid
    Ahmad, Zahoor
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 : 1520 - 1534
  • [10] Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
    Ioerger, Thomas R.
    O'Malley, Theresa
    Liao, Reiling
    Guinn, Kristine M.
    Hickey, Mark J.
    Mohaideen, Nilofar
    Murphy, Kenan C.
    Boshoff, Helena I. M.
    Mizrahi, Valerie
    Rubin, Eric J.
    Sassetti, Christopher M.
    Barry, Clifton E., III
    Sherman, David R.
    Parish, Tanya
    Sacchettini, James C.
    PLOS ONE, 2013, 8 (09):